A+| A| A-|

Company Snapshot


Change Company Name
 
Marksans Pharma Ltd
Pharmaceuticals - Indian - Formulations
BSE Code
524404
NSE Symbol
MARKSANS
P/E
35.54
ISIN Demat
INE750C01026
Div & Yield %
0.42
EPS
5.32
Book Value
32.99
Market Cap (Rs Cr.)
8,567.06
Face Value
1
Stock Price Details
Last Price (₹) 189.20
Change 3.90 (2.06%)
Best Buy (₹) 0
Best Sell (₹) 0
Today's Range 188.65 - 193.95
52-Week Range 162.05 - 358.50
Beta (1 Year) 1.27
Chart
1 Day | 5 Day | 3 Month | 1 Year | 5 Year
Index Details
BSE HC, BSE SmallCap
Corporate Announcements
Relonchem receives UK MHRA's approval for Cetirizine Dihydrochloride 1 mg/ml Oral Solution
Marksans Pharma receives USFDA approval for Loperamide Hydrochloride tablets
Marksans Pharma’s arm gets USFDA approval for Loperamide Hydrochloride 2mg tablets
Relonchem receives UK MHRA's marketing approval for two products
Marksans Pharma consolidated net profit rises 1.58% in the September 2025 quarter
Barometers trade with strong gains; consumer durable shares rally
Marksans Pharma's Goa unit clears USFDA inspection
Marksans Pharma gains after USFDA clears Goa facility with zero observations
Relonchem receives UK MHRA marketing authorization for Exemestane 25mg film-coated tablets
Marksans Pharma Ltd - Marksans Pharma Limited - Updates
Corporate Details
Incorporation Year : 1992
Chairman : Mark Saldanha
Ownership Group : Indian Private
Sector : Pharmaceuticals
Industry : Pharmaceuticals - Indian - Formulations
Registered Office :

Marksans Pharma Ltd
11th Flr GRANDEUR Oshiwara,
Veera Desai Extn Rd Andheri(W),
Mumbai,
Maharashtra - 400053,
Phone : 91-22-40012000,
Fax : 91-22-40012011
E-Mail : companysecretary@marksanspharma.com ; info@marksan
URL : http://www.marksanspharma.com
Investor Returns
Period Date Price(₹) Returns (%)
1Week 12-Nov-2025 196.60 -3.84
1Month 20-Oct-2025 176.70 6.99
3Month 19-Aug-2025 184.45 2.49
6Month 19-May-2025 253.40 -25.39
1Year 19-Nov-2024 305.85 -38.19
Mutual Funds Holding
Scheme Name % Holding Market Value (₹.Cr)
Bandhan Small Cap Fund 0.35 60.73
Kotak Special Opportunites F.. 2.48 46.03
UTI-Small Cap Fund 0.93 45.85
UTI-Aggressive Hybrid Fund 0.60 39.33
UTI-Large & Mid Cap Fund 0.70 36.78
Peer Groups : Pharmaceuticals - Indian - Formulations
Company Last Price(₹) Change(%) 52Week High(₹) 52Week Low(₹) Market Cap(₹)
Torrent Pharmaceuticals Ltd 3,717.75 -0.32 3,880.55 2,891.45 126,229.40
Ajanta Pharma Ltd 2,512.90 -0.13 3,115.00 2,022.05 31,435.05
Gland Pharma Ltd 1,816.80 2.54 2,130.00 1,200.00 29,191.54
ERIS Lifesciences Ltd 1,671.45 3.95 1,909.55 1,130.05 21,902.99
Sai Life Sciences Ltd 874.10 1.09 943.00 635.30 18,172.50